Genetics of noise-induced hearing loss in the mouse model.


Journal

Hearing research
ISSN: 1878-5891
Titre abrégé: Hear Res
Pays: Netherlands
ID NLM: 7900445

Informations de publication

Date de publication:
11 2022
Historique:
received: 02 10 2021
revised: 28 03 2022
accepted: 07 04 2022
pubmed: 8 5 2022
medline: 18 10 2022
entrez: 7 5 2022
Statut: ppublish

Résumé

Hearing loss is the most common sensory deficit worldwide, with the majority of preventable injury attributed to noise-induced hearing loss (NIHL). Highly conserved cochlear genetics between humans and mice have made this animal model a high-yield candidate for better characterizing the biologic and genetic underpinnings of human NIHL. This review aims to summarize advances in understanding the genetics of noise-induced hearing loss in mouse models dating from the early 1990s. We review the genetic mechanisms underpinning NIHL as understood in the mouse model, including histopathological and phenotypic associations, molecular and cellular mechanisms of changes in cochlear structures, synaptopathy and neuropathy, and transcriptomics. We describe variations in pathophysiology of hearing loss between mouse strains, with particular emphasis on susceptibility of different strains to different mechanisms of damage after acoustic trauma, and the potential of novel targeted therapeutic approaches for NIHL based on understanding of genetic mechanisms. Finally, we review the current state of research on the cochlear transcriptome after noise exposure in the mouse and implications for translation of these findings to humans.

Identifiants

pubmed: 35525820
pii: S0378-5955(22)00074-0
doi: 10.1016/j.heares.2022.108505
pii:
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108505

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Auteurs

Samuel Early (S)

Department of Otolaryngology - Head and Neck Surgery, UC San Diego Medical Center, San Diego, CA, USA.

Eric Du (E)

Department of Otolaryngology - Head and Neck Surgery, UC San Diego Medical Center, San Diego, CA, USA; Saint Louis University School of Medicine, St. Louis, MO, USA.

Ely Boussaty (E)

Department of Otolaryngology - Head and Neck Surgery, UC San Diego Medical Center, San Diego, CA, USA.

Rick Friedman (R)

Department of Otolaryngology - Head and Neck Surgery, UC San Diego Medical Center, San Diego, CA, USA. Electronic address: rafriedman@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH